CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
2.265
-0.025 (-1.10%)
At close: Apr 28, 2026, 4:00 PM EDT
2.260
-0.005 (-0.21%)
Pre-market: Apr 29, 2026, 6:04 AM EDT
CNS Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -15.85 | -14.86 | -18.85 | -15.27 | -14.5 | |
| Depreciation & Amortization | 0 | 0 | 0 | 0.01 | 0.01 | |
| Other Amortization | - | - | - | 0.33 | - | |
| Loss (Gain) From Sale of Assets | 0 | -0 | 0 | 0 | - | |
| Stock-Based Compensation | 0.19 | 1.44 | 1.01 | 1.2 | 1.72 | |
| Change in Accounts Payable | 1.54 | -3.63 | 1.32 | 2.3 | 1.04 | |
| Change in Other Net Operating Assets | 0.3 | -0.06 | 2.38 | 0.86 | -1.82 | |
| Operating Cash Flow | -13.81 | -17.11 | -14.14 | -10.56 | -13.54 | |
| Capital Expenditures | -0.02 | -0 | -0 | -0 | -0.01 | |
| Investing Cash Flow | -0.02 | -0 | -0 | -0 | -0.01 | |
| Short-Term Debt Repaid | -0.3 | -0.3 | -0.44 | -0.43 | -0.48 | |
| Total Debt Repaid | -0.3 | -0.3 | -0.44 | -0.43 | -0.48 | |
| Net Debt Issued (Repaid) | -0.3 | -0.3 | -0.44 | -0.43 | -0.48 | |
| Issuance of Common Stock | 14.05 | 23.4 | 5.28 | 16.04 | 4.99 | |
| Other Financing Activities | 0.82 | -0.07 | -0.2 | - | - | |
| Financing Cash Flow | 14.57 | 23.03 | 4.64 | 15.61 | 4.51 | |
| Net Cash Flow | 0.74 | 5.91 | -9.51 | 5.05 | -9.03 | |
| Free Cash Flow | -13.83 | -17.12 | -14.14 | -10.56 | -13.54 | |
| Free Cash Flow Per Share | -31.19 | -537.90 | - | - | - | |
| Cash Interest Paid | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Levered Free Cash Flow | -6.96 | -12.68 | -8 | -5.73 | -7.6 | |
| Unlevered Free Cash Flow | -6.95 | -12.67 | -7.99 | -5.73 | -7.6 | |
| Change in Working Capital | 1.85 | -3.69 | 3.7 | 3.16 | -0.78 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.